Instem - Information Solutions For Life

Regions

• North America
• Europe
• China
• India
• Japan

Canada

Accounting for 2 percent of the world market, pharmaceutical sales within Canada continues to grow and is the 4th fastest growing market, after China, Mexico and Spain.

The Pharmaceutical industry is one of Canada’s most profitable sectors, and although Canadian drug prices are regulated by the government, the industry continues to invest heavily in research & development. Current estimates show that R&D spending will reach nearly $2 billion in 2008.
 
The vast majority of this industry is located within Montreal and Toronto and all are taking advantage of supporting government policies designed to promote innovation, investment and steady growth. Like other countries, the Canadian market is also facing rising R&D costs, and over the last several years have increased their investment in software technologies to help optimize productivity while maintaining safety. In fact, Canadian pharmaceutical organizations have deployed more scientific software applications in the past 5 years than in the previous decade.

As expected, Instem maintains strong client relationships with some of Canada’s leading corporations and government health institutes. Operating within a market where domestic pharmaceutical production is valued at $12 billion, Instem closely supports Canadian clients using its US-based staff delivering its full range of mission-critical software solutions.

Whether it’s to advance domestic or international drug development processes, more Canadian-based scientists start their workday by launching an Instem solution than any other application of its kind.